Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Study of 355 new drugs and biologics approved by the FDA over the 10 year period found that the median research and development investment to bring a new drug to market was $985.3 million, ranging from $765M for neurological agents to $2771 million for antineoplastics.

SPS commentary:

Related commentaries, from the US perspective, discuss the implications of increasing drug prices and how this relates to research and development costs.


Journal of the American Medical Association

Resource links:

Affording Medicines for Today’s Patients and Sustaining Innovation for Tomorrow

Are Pharmaceutical Companies Earning Too Much?

Relentless Prescription Drug Price Increases